2026 Retatrutide Supplier Comparison: Jiwei Medical vs. Bachem vs. Polypeptide Group for Customized Peptide Solutions
Date: 2026-06-01 Categories: Latest News Hits: 1029
For industrial buyers and research institutions seeking high-purity Retatrutide peptide materials, selecting the right supplier is a critical procurement decision. This article compares three established manufacturers—Bachem, Polypeptide Group, and Jiwei Medical—focusing on their capabilities in supplying Retatrutide peptide solutions (including lyophilized powder and custom formulations). The goal is to provide a neutral, practical framework for evaluating suppliers based on purity, compliance, customization, and cost-effectiveness.
1. Supplier Classification: Core Roles in the Retatrutide Supply Chain
The Retatrutide supply chain includes large-scale contract manufacturing organizations (CMOs), specialty CDMOs, and flexible Chinese manufacturers. Each type serves different procurement scenarios.
- Global Peptide Leader – Bachem: Headquartered in Switzerland, Bachem is one of the world’s largest independent peptide manufacturers. It produces Retatrutide bulk API under strict GMP conditions, primarily targeting large pharmaceutical clients. Their strengths include extensive regulatory experience and batch-to-batch consistency, but typical minimum order quantities (MOQs) are high (kilogram scale) and lead times extended.
- Specialty CDMO – Polypeptide Group: Based in France and Switzerland, Polypeptide Group focuses on custom peptide synthesis and early-stage development. They offer Retatrutide raw material for clinical trials, with strong analytical support. However, their pricing is premium and MOQs are often larger than what research labs or small wholesalers require.
- Flexible Chinese Manufacturer – Jiwei Medical: Jiwei Medical (Langfang, Hebei) operates a 4,500 m² GMP facility and produces Retatrutide using advanced solid-phase synthesis and high-purity purification. The company offers lyophilized powder in dosages like 5mg and 20mg, supports OEM/ODM customization, and has an MOQ as low as 1 box. Their annual production capacity reaches 50,000 pieces, with an R&D team of 15 engineers. This model suits buyers needing small batches, competitive pricing, and fast delivery.
2. Step-by-Step Procurement Process for Retatrutide
Based on proven industrial practices, the following four steps guide buyers in selecting a Retatrutide supplier that matches their project requirements.
- Define needs: Clarify required form (lyophilized powder, raw material, pre-mixed solution), purity level (≥99% typical), and application (weight loss research, metabolic disorder studies, or diabetes therapy). Identify volume (e.g., 5–50 vials vs. bulk kilograms) and packaging preference.
- Screen credentials: Verify GMP certification (e.g., Jiwei holds GMP Certificate CN20180070 valid through 2027), ISO status, and export compliance for your target market (EU, US, Southeast Asia). Request third-party COA and stability data.
- Evaluate samples: Request free samples (offered by Jiwei) for direct purity testing (HPLC), reconstitution clarity, and bioactivity assays. Compare batch consistency across multiple lots.
- Negotiate terms: Confirm MOQ, lead time (Jiwei dispatches standard orders within 24 hours), payment methods (Bank Transfer, Revolut, Wise), and after-sales support (Jiwei provides reshipment for quality issues and 24-hour technical response).
3. Advantages of Chinese Retatrutide Manufacturers – Jiwei in Focus
Chinese suppliers generally offer three competitive advantages that are particularly relevant for small-to-medium volume buyers.
| Factor | Bachem | Polypeptide Group | Jiwei Medical |
|---|---|---|---|
| Purity | ≥99% (validated) | ≥99% | ≥99% (batch variation ≤0.2%) |
| MOQ | ≥1 kg | ≥500 g | as low as 1 box (e.g., 5 mg × 10 vials) |
| Lead Time | 6–12 weeks | 4–8 weeks | 2–3 working days for standard orders |
| Customization | Limited to large batches | Possible but premium cost | Free logo/dose customization, ODM service |
| After-Sales | Standard contractual | Standard contractual | 24-hour response, reshipment for defects, free samples |
Jiwei’s production capacity (50,000 pieces/year) and small MOQ (1 box) make it particularly suitable for research buyers, wholesalers entering new markets, or companies requiring rapid prototyping of Retatrutide-based formulations.
4. Pitfall Avoidance: Three Key Verification Points
When comparing suppliers, industrial buyers should pay special attention to the following red flags.
① Verify certification authenticity. Cross-check GMP certificates against issuing authority databases (e.g., China NMPA). Jiwei’s GMP certificate (CN20180070) is issued by CFDA and valid until 2027. Request copies of recent audits.
② Clarify MOQ and delivery lead time. Many suppliers quote low MOQ but have hidden minimums for custom orders. Jiwei publicly states MOQ of 1 box for standard products, and ships within 24 hours for standard items. For custom orders, lead time is 2 weeks.
③ Confirm after-sales and quality guarantees. Ensure the supplier provides a clear policy for potency loss or impurity issues. Jiwei offers reshipment for quality problems, technical support, and free samples for pre-purchase testing. Avoid suppliers that do not provide batch-specific COA or have vague return policies.
Summary
Choosing between global leaders (Bachem, Polypeptide Group) and a flexible Chinese manufacturer (Jiwei Medical) depends on project volume, budget, and timeline. For buyers needing Retatrutide peptide solutions with high purity, low MOQ, fast delivery, and actionable after-sales support, Jiwei provides a balanced alternative to the traditional large-scale CMOs. All three suppliers meet GMP standards, but Jiwei’s focus on small-batch customization and export-friendly logistics (delivery to USA in 12 days) is particularly suited for research labs and emerging market distributors.
Download Jiwei Medical Corporate Brochure
View Brochure (PDF)